Sfoglia per Relatore
Mostrati risultati da 1 a 18 di 18
ANALISI DELLA VARIAZIONE DEI MARCATORI NEOPLASTICI IN CORSO DI TERAPIA CON INIBITORI CDK4/6 IN PAZIENTI AFFETTI DA NEOPLASIA MAMMARIA METASTATICA
2019/2020 PUGLISI, SILVIA
Bespoke Peptide Nucleic Acid Optical Probes for the In-Situ Detection of Mutations in Breast Cancer Tumour Sections
2020/2021 MORRONI, ERMES
Caratterizzazione delle vescicole extracellulari in pazienti con neoplasia mammaria precoce e metastatica rispetto ai controlli sani: studio prospettico.
2021/2022 TALLARICO, ISABEL
CDK4/6 inibitori nel trattamento dei pazienti con carcinoma mammario metastatico HR+/HER2-low: uno studio retrospettivo.
2023/2024 CHESSA, GIULIA
Characterization of extracellular vesicles in plasma of patients with early breast cancer by SiMoA digital ELISA technologies
2020/2021 JIEUNANG MOUAFO, DANIELLE SAMIRA
CORRELATION BETWEEN BIOMOLECULAR, IMMUNO-HISTOLOGICAL VARIABLES AND OCCUPATIONAL EXPOSURE IN LUNG CANCER
2021/2022 FARINATTI, SARA
Determinanti clinici e biologici di risposta all'immunoterapia nel tumore polmonare non a piccole cellule in stadio avanzato: uno studio real life
2019/2020 SCHEMBRI, LUCA
Epidemiological and Clinical Characteristics of 244 Salivary Gland Tumours
2020/2021 BONIUKIEWICZ, ALICJA HELENA
Evolution of gut microbiota and relative metabolomics within the trajectory of healthy, asbestos-exposed individuals and malignant mesothelioma patients: A multi-center pilot study
2022/2023 TSELEKIDOU, PANAGIOTA
HEALTH-RELATED QUALITY OF LIFE AND CLINICAL COMPLEXITY OF A REAL-LIFE COHORT OF PATIENTS WITH ADVANCED HR+/HER2- BREAST CANCER TREATED WITH CDK4/6 INHIBITORS AND ENDOCRINE THERAPY
2022/2023 ZVIELLI, GILAD MOSHE
Incidence and prevalence of pelvic floor dysfunction during adjuvant endocrine treatment of breast cancer: Narrative literature review and study proposal
2022/2023 ZMUDA, PAULINA ANNA
La vitamina B12 e la sua rilevanza clinica nei pazienti oncologici ospedalizzati
2022/2023 RIVA, GIULIA
Percorsi di cura e flussi di pazienti in oncologia durante la pandemia da Covid-19
2019/2020 SARDI, SILVIA
Prognostic role of pre-operative systemic inflammatory markers in hormone receptor-negative HER2-positive early breast cancer
2021/2022 GAFNI, NADAV
Quality of life in patients with metastatic breast cancer treated with CDK4/6 inhibitors: A real-world study
2020/2021 BEN AROCHE, LIOR
Scenari clinici, scelte terapeutiche, sopravvivenza post progressione in pazienti con neoplasia mammaria metastatica trattate con CDK4/6 inibitori
2019/2020 MANTUANO, FRANCESCO
The impact of Covid-19 vaccines on oncologic patients
2021/2022 NAVON, DOR
The prognostic role of variations in tumour markers (CEA, CA15.3) in patients with metastatic breast cancer treated with CDK4/6 inhibitors
2020/2021 BARIGAZZI, CHIARA
Mostrati risultati da 1 a 18 di 18
Legenda icone
- file ad accesso aperto
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile